Thinly traded nano cap Myomo (NYSEMKT:MYO) jumps 51% premarket on increased volume on the heels of its authorization to be a Medicare provider by the Centers for Medicare & Medicaid Services (CMS), allowing it to bill Medicare directly for its devices.
The company is now included in the Medicare Supplier Directory when it delivers its MyoPro powered orthosis in 39 states and the District of Columbia. It is working to complete the requirements in the remaining states.
https://seekingalpha.com/news/3614462-myomo-rallies-on-medicare-provider-status
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.